Results
Eiko LifeSciences FY26 PAT Surges 106% to ₹358 Lakhs
Eiko LifeSciences reported a 106% increase in standalone PAT to ₹358.11 lakhs and 130% consolidated PAT growth to ₹532.47 lakhs for FY 2025-26.
The company acquired a 51% stake in SSM Formulations for
